Your browser doesn't support javascript.
loading
The economic burden of viral severe acute respiratory infections in the Kingdom of Saudi Arabia: A nationwide cost-of-illness study.
Assiri, Abdullah M; Alsubaie, Faisal Saud F; Amer, Samar A; Almuteri, Nawaf Ali M; Ojeil, Rita; Dhopte, Pratik Ramesh; Alsaqa'aby, Mai; Alotaibi, Adel Fahad M.
Affiliation
  • Assiri AM; Deputyship for Preventive Health, Ministry of Health, Riyadh, Saudi Arabia.
  • Alsubaie FSF; Deputyship for Preventive Health, Ministry of Health, Riyadh, Saudi Arabia.
  • Amer SA; Deputyship for Preventive Health, Ministry of Health, Riyadh, Saudi Arabia.
  • Almuteri NAM; Deputyship for Preventive Health, Ministry of Health, Riyadh, Saudi Arabia.
  • Ojeil R; Health Economic and Outcomes Research (HEOR)-Real-World Evidence (RWE) department, IQVIA, Beirut, Lebanon.
  • Dhopte PR; Health Economic and Outcomes Research (HEOR)-Real-World Evidence (RWE), IQVIA, India.
  • Alsaqa'aby M; Health Economic and Outcomes Research (HEOR)-Real-World Evidence (RWE), IQVIA Solutions Limited, Riyadh, KSA.
  • Alotaibi AFM; Deputyship for Preventive Health, Ministry of Health, Riyadh, Saudi Arabia.
IJID Reg ; 10: 80-86, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38173861
ABSTRACT

Objectives:

The authors conducted a study to estimate the rising disease and economic burden of viral severe acute respiratory infections and their management, including COVID-19, respiratory syncytial virus, and influenza types A and B, in early and delayed diagnosis scenarios in the Kingdom of Saudi Arabia from a national perspective.

Methods:

This cross-sectional study was conducted in May 2022 using a de novo Excel-based universal cost-of-illness calculator model. The study used primary data, such as expert interviews, as well as secondary data from a thorough literature search.

Results:

The total economic burden of viral severe acute respiratory infections in patients with an early diagnosis was lower than those with a delayed diagnosis among patients with complications, both from the payer's (United States dollar [USD] 3846 million vs USD 4726 million) and societal (USD 4048 million vs USD 5020 million, respectively) perspectives. The major cost driver of the total economic burden for both early and delayed diagnosis was disease management costs 49% (USD 1880 million) and 58% (USD 2730 million), respectively.

Conclusions:

In the Kingdom of Saudi Arabia, the total economic burden for COVID-19, influenza (epidemic phase), and respiratory syncytial virus was higher with a delayed diagnosis vs an early diagnosis, emphasizing the importance of using a broader diagnostic method.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Observational_studies / Screening_studies Language: En Journal: IJID Reg Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Observational_studies / Screening_studies Language: En Journal: IJID Reg Year: 2024 Document type: Article Affiliation country: